Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity.
暂无分享,去创建一个
B. Stripp | R. Flavell | J. Whitsett | J. Elias | D. Picarella | J. Rankin | G. Geba | B. DiCosmo | Jeffrey A. Whitsett | Jack A. Elias | John A. Rankin | Barry R. Stripp | Richard A. Flavell
[1] M. Denis. Interleukin‐6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL‐6 or direct administration of IL‐6 , 1992, Journal of leukocyte biology.
[2] B. Stripp,et al. cis-acting elements that confer lung epithelial cell expression of the CC10 gene. , 1992, The Journal of biological chemistry.
[3] C. Stewart,et al. Inhibitory role of interleukin‐6 in macrophage proliferation , 1992, Journal of leukocyte biology.
[4] M. Tsan,et al. IL-6 enhances TNF-alpha- and IL-1-induced increase of Mn superoxide dismutase mRNA and O2 tolerance. , 1992, American Journal of Physiology.
[5] E. Fuchs,et al. Interleukin 6: insights to its function in skin by overexpression in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Broide,et al. Cytokines in symptomatic asthma airways. , 1992, The Journal of allergy and clinical immunology.
[7] S. Mattoli,et al. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. , 1992, The Journal of allergy and clinical immunology.
[8] S. Durham,et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. , 1992, Journal of immunology.
[9] S. Durham,et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.
[10] A. Capron,et al. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease , 1992, The Journal of experimental medicine.
[11] A. Capron,et al. Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. , 1991, The Journal of allergy and clinical immunology.
[12] S. Durham,et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. , 1991, The Journal of allergy and clinical immunology.
[13] L. Allegra,et al. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. , 1991, The Journal of allergy and clinical immunology.
[14] H. Nakauchi,et al. Effects of interleukin 3, interleukin 6, and granulocyte colony-stimulating factor on sorted murine splenic progenitor cells. , 1991, Experimental hematology.
[15] S. Durham,et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects , 1991, The Journal of experimental medicine.
[16] S. Holgate,et al. The role of the eosinophil in asthma. , 1991, The American review of respiratory disease.
[17] T. Hirano,et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[18] Sehgal Pb. Interleukin-6: a regulator of plasma protein gene expression in hepatic and non-hepatic tissues. , 1990 .
[19] C. Corrigan,et al. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. , 1990, The American review of respiratory disease.
[20] S. Johnston,et al. Cellular and chemical mediators--their roles in allergic diseases. , 1990, Current opinion in immunology.
[21] M. Jourdan,et al. Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. , 1990, Arthritis and rheumatism.
[22] G. Gleich. The eosinophil and bronchial asthma: current understanding. , 1990, The Journal of allergy and clinical immunology.
[23] J. Vilček,et al. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. , 1989, Journal of immunology.
[24] J. Miyazaki,et al. IgG1 plasmacytosis in interleukin 6 transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[25] T. Komori,et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease , 1989 .
[26] L. Harrison,et al. Evidence for IL-6 production by and effects on the pancreatic beta-cell. , 1989, Journal of immunology.
[27] R. Geha,et al. Endogenous interleukin 6 plays an obligatory role in interleukin 4‐dependent human IgE synthesis , 1989, European journal of immunology.
[28] T. Kupper,et al. Production of IL‐6 by Keratinocytes , 1989 .
[29] T. Hirano,et al. Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. , 1989, Clinical immunology and immunopathology.
[30] G. Trinchieri,et al. A synergistic interaction of IL-6 and IL-1 mediates the thymocyte-stimulating activity produced by recombinant IL-1-stimulated fibroblasts. , 1989, Journal of immunology.
[31] A. Haman,et al. Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia. , 1988, Blood.
[32] J. Drazen,et al. Pulmonary responses to bronchoconstrictor agonists in the mouse. , 1988, Journal of applied physiology.
[33] C. Corrigan,et al. T LYMPHOCYTE ACTIVATION IN ACUTE SEVERE ASTHMA , 1988, The Lancet.
[34] C. Uyttenhove,et al. T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor , 1988, The Journal of experimental medicine.
[35] A Muraguchi,et al. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells , 1988, The Journal of experimental medicine.
[36] F. Ruddle,et al. Cloning and expression of murine lymphotoxin cDNA. , 1987, Journal of Immunology.
[37] G. Hunninghake,et al. Late asthmatic responses: Inquiry into mechanisms and significance , 1985, Clinical reviews in allergy.
[38] H. Sluiter,et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. , 1985, The American review of respiratory disease.
[39] P. Greengard,et al. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections , 1983, The Journal of cell biology.
[40] M. Dunnill. THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSA , 1960, Journal of clinical pathology.
[41] J. Mead,et al. Mechanics of respiration in unanesthetized guinea pigs. , 1958, The American journal of physiology.
[42] R. Zitnik,et al. Interleukin-6 and the lung , 1993 .
[43] C. Corrigan,et al. T cells and eosinophils in the pathogenesis of asthma. , 1992, Immunology today.
[44] N. Yoshimura,et al. Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients. , 1991, Transplantation.
[45] D. House,et al. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. , 1991, American journal of respiratory cell and molecular biology.
[46] D. Remick,et al. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. , 1991, The American journal of pathology.
[47] 堀井 康弘. Involvement of IL-6 in mesangial proliferative glomerulonephritis , 1990 .
[48] C. Dinarello,et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.
[49] L. Aarden,et al. Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. , 1988, Scandinavian journal of rheumatology.
[50] R. Pack,et al. The cells of the tracheobronchial epithelium of the mouse: a quantitative light and electron microscope study. , 1981, Journal of anatomy.